跳至主要内容
临床试验/NCT01373541
NCT01373541已完成不适用

Effect of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Infants in China: a Double Blind, Multi-center, Randomized, Controlled Trial

Enzymotec1 个研究点 分布在 1 个国家目标入组 171 人开始时间: 2011年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
171
试验地点
1
主要终点
Soaped and total fatty acids content in infant's stool samples collected at the age of 6 weeks and measured by stool biochemistry analysis

研究概览

简要总结

The purpose of this study is to determine the effect of infant formula with high percentage of palmitic acid at the sn-2 position (InFat™) on improving fat absorption and general gastrointestinal tolerance in Chinese formula-fed term infants.

详细描述

The purpose of this study is to assess the efficacy of infant formula with high percentage of palmitic acid at the sn-2 position (InFat™) as compared to standard vegetable oil based infant formula on general gastrointestinal tolerance and fat absorption, reducing calcium soaps formation and stool hardness in Chinese formula-fed term infants.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
1 Day 至 14 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Parental/legal guardian written informed consent;
  • The mother had unequivocally decided not to breast-feed (for formula fed infants) or to breastfeed (for human milk fed infants).
  • Term infant of Chinese origin born at 37-42 gestation weeks
  • Birth weight appropriate for gestational age (AGA), 2500-4000grams
  • The infant is apparently healthy at birth and entry of study.

排除标准

  • Adverse maternal, fetal or infant medical history that can potentially affect efficacy parameters, tolerance, growth and/or development
  • The infant is not a singleton newborn

结局指标

主要结局

Soaped and total fatty acids content in infant's stool samples collected at the age of 6 weeks and measured by stool biochemistry analysis

时间窗: 6 postnatal weeks

次要结局

  • Number of participants with adverse events and concomitant medications as a measure of safety and tolerability(Baseline, 6,12 and 24 postnatal weeks)
  • Anthropometric parameters: body length, body weight, and head circumferences at each visit(Baseline, 6, 12 and 24 postnatal weeks)
  • Dietary, stool consistency and well being recorded by 3 day questionnaires(6, 12 and 24 postnatal weeks)
  • Bone speed of sound measured by ultrasonic device at each visit(Baseline, 6,12 and 24 postnatal weeks)

研究者

发起方
Enzymotec
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验